We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Technique for Islet Cell Transplant

By HospiMedica staff writers
Posted on 14 Dec 2005
A new, minimally invasive technique has been developed to transplant healthy islet cells into patients with type 1 diabetes in order to restore insulin, according to a recent study.

"We used ultrasound guidance to inject donor cells into the portal vein of diabetic patients, which is accessed through the skin,” said study co-author Saravanan Krishnamoorthy, M.D., a radiology resident at the University of Minnesota Medical School (Minneapolis, MI, USA). More...
"This is a safe method of cell transplantation that could potentially become a same-day procedure.”

The scientists used a steroid-free protocol to suppress the immune system, so that the body would accept the transplanted cells. They developed a "sandwich technique” procedure to close the access site, layering applications of gel-foam and coil to seal it. The sandwich closure is considered a safe method that prevents many of the complications common to previous techniques used to transplant islet cells.

Thirty days after the procedure, all 13 patients involved were producing insulin without requiring supplemental injections, and none experienced major complications. Liver function tests and blood cell counts were monitored carefully during this time. The study was presented at the annual meeting of the Radiological Society of America (RSNA) in November/December 2005 in Chicago (IL, USA).

In type 1 diabetes, the body does not produce insulin, usually because of the destruction of insulin-producing islet beta cells in the pancreas.




Related Links:
University of Minnesota Medical School

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.